ENvue Medical, Inc. (FEED) Return on equity 2017–2025
ENvue Medical, Inc. (FEED) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-54.3%FY2025 · since FY2017: -136.6% → -54.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -54.3% | +536.6 pp |
| FY2024 | -590.9% | -497.9 pp |
| FY2023 | -93.0% | +75.5 pp |
| FY2022 | -168.5% | +57.7 pp |
| FY2021 | -226.2% | -45.5 pp |
| FY2020 | -180.7% | +249.4 pp |
| FY2019 | -430.1% | +467.1 pp |
| FY2018 | -897.2% | -760.6 pp |
| FY2017 | -136.6% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More FEED financial trends
FEED RevenueFEED Net incomeFEED Net marginFEED Gross profitFEED Gross marginFEED Operating incomeFEED Operating marginFEED Operating cash flowFEED Free cash flowFEED Capital expendituresFEED Stock buybacksFEED Dividends paidFEED Total assetsFEED Total liabilitiesFEED Shareholders’ equityFEED overview →